SELLAS Life Sciences Group annual free cash flow
2010
2011
2013
2014
2015
2016
SELLAS Life Sciences Group Free Cash Flow (FCF) History (SLS)
SELLAS Life Sciences Group reported −$11.9M in free cash flow for fiscal 2016, an increase of $36.5M from the previous fiscal year.
View full SELLAS Life Sciences Group company overviewSELLAS Life Sciences Group free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2016 | 2016-12-31 | −$11.9M | $36.5M | — | — |
| 2015 | 2015-12-31 | −$48.3M | −$5.4M | — | — |
| 2014 | 2014-12-31 | −$42.9M | −$13.7M | — | −460.63% |
| 2013 | 2013-12-31 | −$29.2M | −$14.5M | — | −1176.08% |
| 2011 | 2011-12-31 | −$14.7M | −$4.4M | — | — |
| 2010 | 2010-12-31 | −$10.4M | — | — | — |
SELLAS Life Sciences Group quarterly free cash flow
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2016 | 2016-12-31 | $25.1M | $40.4M | — | — |
| Q3 2016 | 2016-09-30 | −$12.2M | −$2.7M | — | — |
| Q2 2016 | 2016-06-30 | −$11.5M | $385,000 | — | — |
| Q1 2016 | 2016-03-31 | −$13.2M | −$1.6M | — | — |
| Q4 2015 | 2015-12-31 | −$15.4M | −$4.6M | — | — |
| Q3 2015 | 2015-09-30 | −$9.5M | $1.6M | — | — |
| Q2 2015 | 2015-06-30 | −$11.9M | $1.1M | — | −351.15% |
| Q1 2015 | 2015-03-31 | −$11.6M | −$3.5M | — | −420.87% |
| Q4 2014 | 2014-12-31 | −$10.7M | −$2.7M | — | −336.24% |
| Q3 2014 | 2014-09-30 | −$11.1M | −$7.0M | — | −687.28% |
| Q2 2014 | 2014-06-30 | −$13.0M | −$9.6M | — | −556.80% |
| Q1 2014 | 2014-03-31 | −$8.1M | −$4.0M | — | −371.38% |
| Q3 2013 | 2013-09-30 | −$8.1M | −$5.0M | — | −691.20% |
| Q4 2011 | 2011-12-31 | −$4.2M | −$1.9M | — | — |
| Q3 2011 | 2011-09-30 | −$3.4M | — | — | — |
| Q2 2011 | 2011-06-30 | −$4.1M | — | — | — |
| Q1 2011 | 2011-03-31 | −$3.1M | — | — | — |
| Q3 2010 | 2010-09-30 | −$2.2M | — | — | — |
SELLAS Life Sciences Group free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$10.4M to −$11.9M, a net decrease of $1.5M. SELLAS Life Sciences Group's latest reported quarter, Q4 2016, generated $25.1M in free cash flow, an increase of $40.4M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review SELLAS Life Sciences Group filings at SEC.gov ↗